Integrative Analysis of Checkpoint Blockade Response in Advanced Non-Small Cell Lung Cancer
Arvind Ravi, Justin F. Gainor, Monica B. Arniella, Mark Holton, Samuel S. Freeman, Chip Stewart, Ignaty Leshchiner, Jaegil Kim, Yo Akiyama, Aaron Timothy Griffin, Natalie I. Vokes, Mustafa Sakhi, Vashine Kamesan, Hira A. Rizvi, Biagio Ricciuti, , Matthew David Hellmann
This study identifies molecular and immune features associated with response to anti-PD-(L)1 therapy in NSCLC using a cohort of 393 patients.
bioRxiv · Mar 21, 2022 · PreprintGenomics